Clinical Experience of Switching Anti-VEGF Therapy from Ranibizumab to Aflibercept in Age-Related Choroidal Neovascularization
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Experience of Switching Anti-VEGF Therapy from Ranibizumab to Aflibercept in Age-Related Choroidal Neovascularization
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF OPHTHALMOLOGY
Volume 27, Issue 3, Pages 342-345
Publisher
SAGE Publications
Online
2016-10-14
DOI
10.5301/ejo.5000861
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CONVERSION TO AFLIBERCEPT THERAPY VERSUS CONTINUING WITH RANIBIZUMAB THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DEPENDENT ON MONTHLY RANIBIZUMAB TREATMENT
- (2016) Irmela Mantel et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- One-Year Outcomes of Aflibercept in Recurrent or Persistent Neovascular Age-Related Macular Degeneration
- (2015) Cheryl A. Arcinue et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Switch to Aflibercept in the Treatment of Neovascular AMD: One-Year Results in Clinical Practice
- (2015) Jo�o Pinheiro-Costa et al. OPHTHALMOLOGICA
- SWITCHING TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION FROM BEVACIZUMAB TO RANIBIZUMAB
- (2015) Elad Moisseiev et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Injection frequency and anatomic outcomes 1 year following conversion to aflibercept in patients with neovascular age-related macular degeneration
- (2014) Wyatt B Messenger et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Response to Aflibercept After Frequent Re-treatment With Bevacizumab or Ranibizumab in Eyes With Neovascular AMD
- (2014) Mariana R. Thorell et al. Ophthalmic Surgery Lasers & Imaging Retina
- Conversion to Aflibercept For Chronic Refractory Or Recurrent Neovascular Age-Related Macular Degeneration
- (2013) Yoshihiro Yonekawa et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Short-Term Outcomes of Aflibercept for Neovascular Age-Related Macular Degeneration in Eyes Previously Treated With Other Vascular Endothelial Growth Factor Inhibitors
- (2013) Vincent Y. Ho et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab
- (2013) Benjamin Bakall et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab
- (2013) Hyung Cho et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration
- (2013) Andrew A. Chang et al. OPHTHALMOLOGY
- VISUAL AND ANATOMICAL OUTCOMES OF INTRAVITREAL AFLIBERCEPT IN EYES WITH PERSISTENT SUBFOVEAL FLUID DESPITE PREVIOUS TREATMENTS WITH RANIBIZUMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2013) Nishant Kumar et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- TACHYPHYLAXIS AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
- (2009) FARZIN FOROOGHIAN et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Is There Tachyphylaxis to Intravitreal Anti-Vascular Endothelial Growth Factor Pharmacotherapy in Age-Related Macular Degeneration?
- (2008) Shlomit Schaal et al. OPHTHALMOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started